ArticleCureus2026
Pediatric Central Giant Cell Granuloma in the Nasal Cavity: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central giant cell granuloma (CGCG) is a rare benign and locally aggressive osteolytic lesion that predominantly affects the mandible and maxilla in the head and neck region. Involvement of the nasal cavity is extremely uncommon in children, with only a few cases reported, and is typically managed via external or transoral surgical approaches. We report CGCG in a healthy 13-year-old girl presenting as an expansile lesion of the right nasal cavity with adjacent bony remodeling. Diagnosis was established through radiological and histopathologic evaluation. The tumor was resected entirely using an endoscopic endonasal technique without an external approach. The patient remained disease-free and asymptomatic at 36 months. This report is complemented by a concise literature review that addresses the pathogenesis, diagnostic considerations, and management strategies for CGCG. The case highlights the feasibility of a minimally invasive approach without external access for managing pediatric nasal CGCG. This technique achieved complete excision with excellent cosmetic and functional outcomes and is considered a safe alternative to more extensive surgical procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.